Brigatinb
- Strength
- 90mg
- Manufacturer
- Availability
- Available to source
Ask for price
Brigatinib 药品批文：03 L 0954/23 90mg
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Brigatinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on, or are intolerant to, crizotinib.
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
Related medicines
